Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.

Purpose: To investigate the efficacy and safety of subconjunctival bevacizumab injection for the treatment of impending recurrent pterygium.

Methods: A prospective, randomized, single-masked, controlled trial was conducted in 80 patients with impending recurrent pterygium. Patients were randomized into 4 groups using random tables: 20 patients served as a control and treatment groups received a single intralesional injection of 1.

Progressive keratolysis with pseudopterygium associated with erythema elevatum diutinum.

Objective: To report a patient with a rare case of progressive keratolysis with pseudopterygium associated with erythema elevatum diutinum (EED).

Design: Interventional case report and literature review.

Participant: One patient with ocular presentation of EED was identified.